Distinction between 2′- and 3′-Phosphate Isomers of a Fluorescent NADPH Analogue Led to Strong Inhibition of Cancer Cells Migration
Raoul Manuel,
Michelle de Souza Lima,
Sébastien Dilly,
Sylvain Daunay,
Patricia Abbe,
Elodie Pramil,
Stéphanie Solier,
Fabienne Guillaumond,
Sarah-Simha Tubiana,
Alexandre Escargueil,
João Antonio Pêgas Henriques,
Nathalie Ferrand,
Irène Erdelmeier,
Jean-Luc Boucher,
Gildas Bertho,
Israel Agranat,
Stéphane Rocchi,
Michèle Sabbah,
Anny Slama Schwok
Affiliations
Raoul Manuel
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Michelle de Souza Lima
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Sébastien Dilly
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Sylvain Daunay
Innoverda, Biopark Villejuif, F-94800 Villejuif, France
Patricia Abbe
Centre Méditerranéen de Médecine Moléculaire (C3M), INSERM U1065, Team 12, F-06204 Nice, France
Elodie Pramil
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Stéphanie Solier
Gustave Roussy Cancer Center, INSERM U1170, F-94805 Villejuif, France
Fabienne Guillaumond
Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, Aix-Marseille Univ., CNRS, UMR 7258, Institut Paoli-Calmettes, F-13288 Marseille, France
Sarah-Simha Tubiana
Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, Aix-Marseille Univ., CNRS, UMR 7258, Institut Paoli-Calmettes, F-13288 Marseille, France
Alexandre Escargueil
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
João Antonio Pêgas Henriques
Departamento de Biofísica/Centro de Biotecnologia, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre 90040-060, Brazil
Nathalie Ferrand
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Irène Erdelmeier
Innoverda, Biopark Villejuif, F-94800 Villejuif, France
Jean-Luc Boucher
CNRS UMR 8601, University Paris Descartes, F-75006 Paris, France
Gildas Bertho
CNRS UMR 8601, University Paris Descartes, F-75006 Paris, France
Israel Agranat
Organic Chemistry, Institute of Chemistry, Philadelphia Bldg #212, Edmond J. Safra Campus, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel
Stéphane Rocchi
Centre Méditerranéen de Médecine Moléculaire (C3M), INSERM U1065, Team 12, F-06204 Nice, France
Michèle Sabbah
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Anny Slama Schwok
Cancer Biology and Therapeutics Team, INSERM, UMR_S 938, Centre de Recherche Saint-Antoine, Sorbonne Université, F-75012 Paris, France
Specific inhibition of NADPH oxidases (NOX) and NO-synthases (NOS), two enzymes associated with redox stress in tumor cells, has aroused great pharmacological interest. Here, we show how these enzymes distinguish between isomeric 2′- and 3′-phosphate derivatives, a difference used to improve the specificity of inhibition by isolated 2′- and 3′-phosphate isomers of our NADPH analogue NS1. Both isomers become fluorescent upon binding to their target proteins as observed by in vitro assay and in vivo imaging. The 2′-phosphate isomer of NS1 exerted more pronounced effects on NOS and NOX-dependent physiological responses than the 3′-phosphate isomer did. Docking and molecular dynamics simulations explain this specificity at the level of the NADPH site of NOX and NOS, where conserved arginine residues distinguished between the 2′-phosphate over the 3′-phosphate group, in favor of the 2′-phosphate.